Europe is not happy with President Trump’s demand that drug manufacturers provide U.S. consumers with equitable pricing.
If President Trump will no longer permit Americans to pay the research production costs for pharmaceutical companies through high prices, essentially subsiding pharmaceutical costs for the world, then Rx companies will have to increase their prices throughout Europe. This is making the Europeans very unhappy.
